Have a personal or library account? Click to login
The levels of bone alkaline phosphatase (BALP) and soluble epidermal growth factor receptor-2 (ECD/HER-2) in pediatric patients with osteosarcoma during clinical treatment Cover

The levels of bone alkaline phosphatase (BALP) and soluble epidermal growth factor receptor-2 (ECD/HER-2) in pediatric patients with osteosarcoma during clinical treatment

Journal of Mother and Child
Volume 22 (2018): Issue 1 (March 2018)
By: Magdalena Rychłowska-Pruszyńska,  Joanna Gajewska,  Jadwiga Ambroszkiewicz,  Marek Karwacki and  Katarzyna Szamotulska  
Open Access
|Apr 2018

Authors

Magdalena Rychłowska-Pruszyńska

magdarychlowska@wp.pl

Department of Surgical Oncology for Children and Youth, Institute of Mother and Child, Warsaw, Poland

Joanna Gajewska

Department of Screening and Metabolic Diagnostics, Institute of Mother and Child, Warsaw, Poland

Jadwiga Ambroszkiewicz

Department of Screening and Metabolic Diagnostics, Institute of Mother and Child, Warsaw, Poland

Marek Karwacki

Department of Surgical Oncology for Children and Youth, Institute of Mother and Child, Warsaw, Poland

Katarzyna Szamotulska

Department of Epidemiology and Biostatistics, Institute of Mother and Child, Warsaw, Poland
DOI: https://doi.org/10.34763/devperiodmed.20182201.5864 | Journal eISSN: 2719-535X | Journal ISSN: 2719-6488
Journal RSS Feed
Language: English
Page range: 58 - 64
Submitted on: Nov 29, 2017
|
Accepted on: Dec 6, 2017
|
Published on: Apr 12, 2018
Published by: Institute of Mother and Child
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
bone tumor,
prognostic marker,
children,
adolescence
Related subjects:
Medicine,
Clinical medicine,
Pediatrics and juvenile medicine,
Paediatric haematology and oncology,
Public health

© 2018 Magdalena Rychłowska-Pruszyńska, Joanna Gajewska, Jadwiga Ambroszkiewicz, Marek Karwacki, Katarzyna Szamotulska, published by Institute of Mother and Child
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 22 (2018): Issue 1 (March 2018)Next article